ESR2 and prostate carcinoma: In two cohorts of prostate cancer patients in which data are available for both gene expression and overall survival51 or disease-free survival (DFS)52, we examined the correlation between ZFHX3 and ESR2 expression statuses with overall or disease-free survival.